Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · cited 2×
“45).”
BackgroundEffect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431 · cited 2×
“42 and 43).”
MethodSTING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Ishikawa, H., Ma, Z., & Barber, G. N. (2009) · Nature · doi:10.1038/nature08476 · Cited by 2,759
Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A., & Siegwart, D. J. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0669-6 · Cited by 2,383 · cited 2×
“46) are released over time in vitro.”
BackgroundSTING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Woo, S.-R., Fuertes, M. B., Corrales, L., Spranger, S., Furdyna, M. J., Leung, M. Y. K., Duggan, R., Wang, Y., Barber, G. N., Fitzgerald, K. A., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.017 · Cited by 1,917
CGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING.
Ablasser, A., Goldeck, M., Cavlar, T., Deimling, T., Witte, G., Röhl, I., Hopfner, K.-P., Ludwig, J., & Hornung, V. (2013) · Nature · doi:10.1038/nature12306 · Cited by 1,695 · cited 2×
“To achieve exogenous STING activation, small-molecule mimetics of CDNs have been synthesized 11–13 , leading to notable efficacy in preclinical models, which was further enhanced when combined with other therapeutic modalities 14–16 .”
BackgroundMechanisms of resistance to immune checkpoint inhibitors
Jenkins, R. W., Barbie, D. A., & Flaherty, K. T. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.434 · Cited by 1,383
STING: infection, inflammation and cancer.
Barber, G. N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3921 · Cited by 1,313 · cited 2×
“The stimulation of innate immune danger sensors, such as the cytosolic cyclic dinucleotide (CDN) sensor stimulator of interferon genes (STING), is a powerful therapeutic strategy to generate durable antitumour immune responses 1–4 .”
BackgroundType I interferons in anticancer immunity
Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J., & Kroemer, G. (2015) · Nature Reviews Immunology · doi:10.1038/nri3845 · Cited by 1,305
Structure and function of the immune system in the spleen
Lewis, S. M., Williams, A., & Eisenbarth, S. C. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau6085 · Cited by 1,301 · cited 1×
“Given the contributions of the spleen to peripheral immunity 29,30 , further work describing its contribution to the efficacy and mechanisms of NP-mediated CDN immunotherapy would be insightful.”
Background
Cited by
Trials and Tribulations of MicroRNA Therapeutics
Seyhan, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031469 · Cited by 381
“A recent study showcased the increased antitumor effectiveness of STING agonists through the covalent attachment of cyclic dinucleotides (CDN) to polymer nanoparticle (poly( β -amino ester) formulation for intravenous delivery [229].”
BackgroundHu, H., Zheng, S., He, C., Zheng, Y., Wei, Q., Chen, S., Wu, Z., Xu, Y., Zhao, B., & Yan, C. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02502-8 · Cited by 43
Metadata
- Authors
- Dosta, P., Cryer, A. M., Dion, M. Z., Shiraishi, T., Langston, S. P., Lok, D., Wang, J., Harrison, S., Hatten, T., Ganno, M. L., Appleman, V. A., Taboada, G. M., Puigmal, N., Ferber, S., Kalash, S., Prado, M., Rodríguez, A. L., Kamoun, W. S., Abu-Yousif, A. O., & Artzi, N.
- Venue
- Nature Nanotechnology
- Published
- 2023-07-13
- Volume
- 18
- Issue
- 11
- Pages
- 1351-1363
- ISSN
- 1748-3387 (ISSN-L)
- 1748-3395
- OpenAlex
- W4384206592
- Cited by
- 161
- References
- 18
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles. https://app.cochat.ai/papers/10.1038/s41565-023-01447-7
- The paper
- Dosta, P., Cryer, A. M., Dion, M. Z., Shiraishi, T., Langston, S. P., Lok, D., Wang, J., Harrison, S., Hatten, T., Ganno, M. L., Appleman, V. A., Taboada, G. M., Puigmal, N., Ferber, S., Kalash, S., Prado, M., Rodríguez, A. L., Kamoun, W. S., Abu-Yousif, A. O., & Artzi, N. (2023). Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles. Nature Nanotechnology. https://doi.org/10.1038/s41565-023-01447-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.